The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma

Table 1

Association between PTPRH expression and clinicopathological features of LUAD from TCGA database.

	Low PTPRH	High PTPRH	value
	()	()
Age (years)
	103 (43.3%)	107 (45.1%)	0.75
	135 (56.7%)	130 (54.9%)
Gender
Female	135 (56.7%)	119 (50.2%)	0.183
Male	103 (43.3%)	118 (49.8%)
T
T1	94 (39.5%)	68 (28.7%)	0.0073
T2	124 (52.1%)	127 (53.6%)
T3	14 (5.9%)	30 (12.7%)
T4	6 (2.5%)	12 (5.1%)
N
N0	168 (70.6%)	145 (61.2%)	0.194
N1	39 (16.4%)	51 (21.5%)
N2	30 (12.6%)	40 (16.9%)
N3	1 (0.4%)	1 (0.4%)
Stage
Stage I	143 (60.1%)	113 (47.7%)	0.0335
Stage II	53 (22.3%)	64 (27.0%)
Stage III	35 (14.7%)	45 (19.0%)
Stage IV	7 (2.9%)	15 (6.3%)